The estimated Net Worth of Michael Weintraub is at least $4.42 Million dollars as of 5 August 2021. Mr. Weintraub owns over 8,236 units of Phreesia Inc stock worth over $4,088,579 and over the last 5 years he sold PHR stock worth over $0. In addition, he makes $329,864 as Independent Chairman of the Board at Phreesia Inc.
Sign up
Mr. Weintraub PHR stock SEC Form 4 insiders trading
Michael has made over 7 trades of the Phreesia Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 8,236 units of PHR stock worth $16,719 on 5 August 2021.
The largest trade he's ever made was exercising 35,000 units of Phreesia Inc stock on 19 January 2021 worth over $71,050. On average, Michael trades about 9,167 units every 45 days since 2020. As of 5 August 2021 he still owns at least 175,325 units of Phreesia Inc stock.
You can see the complete history of Mr. Weintraub stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Weintraub biography
Michael Weintraub serves as Independent Chairman of the Board of the Company. Mr. Weintraub serves as Co-Founder and Managing Partner of Ardan Equity Partners, LLC, a healthcare enterprise software private equity firm, since April 2019. Previously, Mr. Weintraub served as Managing Partner of Optum Venture Management LLC, a company focused on digital health innovation, from 2017 to 2018. Mr. Weintraub was Co-Founder and Chief Executive Officer of Humedica, Inc., a population health management and big data company, from 2008 until 2013. After Humedica, Inc. was acquired by UnitedHealth Group, or UHG, in 2013, Mr. Weintraub served as President and Chief Executive Officer of Optum Analytics, UHG, from 2013 until 2017. Prior to launching Humedica, Inc., Mr. Weintraub served as Senior Managing Director at Leerink Partners LLC, a healthcare investment bank. Mr. Weintraub also served as Chief Executive Officer of PharMetrics, Inc. from 2001 until 2005, a healthcare informatics company, which was acquired by IMS Health, Inc., now IQVIA Holdings Inc., in 2005. Mr. Weintraub currently serves as chairman of the board of directors of BroadReach Healthcare, LLC, a global healthcare company, Holmusk Ltd, and Corrona, LLC as a member of the board of directors of Oncology Analytics, Newfire, LLC, and The College Diabetes Network, and as an advisory board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital. Mr. Weintraub also focuses on healthcare innovation as an Entrepreneur in Residence at Harvard Business School. Mr. Weintraub received his bachelor’s degree in Economics from Brandeis University in Boston, Massachusetts and an M.B.A. from Harvard Business School in Boston, Massachusetts.
What is the salary of Michael Weintraub?
As the Independent Chairman of the Board of Phreesia Inc, the total compensation of Michael Weintraub at Phreesia Inc is $329,864. There are 8 executives at Phreesia Inc getting paid more, with Chaim Indig having the highest compensation of $10,474,400.
How old is Michael Weintraub?
Michael Weintraub is 61, he's been the Independent Chairman of the Board of Phreesia Inc since . There are 3 older and 14 younger executives at Phreesia Inc. The oldest executive at Phreesia Inc is Mark Smith, 68, who is the Independent Director.
What's Michael Weintraub's mailing address?
Michael's mailing address filed with the SEC is C/O PHREESIA, INC., 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803.
Insiders trading at Phreesia Inc
Over the last 5 years, insiders at Phreesia Inc have traded over $277,935,884 worth of Phreesia Inc stock. The most active insiders traders include Edward L Cahill, Venture Partners Ii, L.P.Hl... und Scott Perricelli. On average, Phreesia Inc executives and independent directors trade stock every 8 days with the average trade being worth of $1,320,099. The most recent stock trade was executed by Allison C Hoffman on 26 August 2024, trading 14,110 units of PHR stock currently worth $367,283.
What does Phreesia Inc do?
leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.
What does Phreesia Inc's logo look like?
Complete history of Mr. Weintraub stock trades at Phreesia Inc
Phreesia Inc executives and stock owners
Phreesia Inc executives and other stock owners filed with the SEC include:
-
Chaim Indig,
Chief Executive Officer, Director -
Evan Roberts,
Chief Operating Officer -
Thomas Altier,
Chief Financial Officer -
Chaim Indig,
Co-Founder, CEO & Director -
David Linetsky,
Sr. VP of Life Sciences -
Gillian Munson,
Independent Director -
Cheryl Pegus,
Independent Director -
Charles Kallenbach,
General Counsel, Secretary -
Michael Weintraub,
Independent Chairman of the Board -
Allison C. Hoffman,
Gen. Counsel & Sec. -
Mark Smith,
Independent Director -
Edward Cahill,
Independent Director -
Lainie Goldstein,
Director -
Dusty Lieb,
Director -
Balaji Gandhi,
Vice President - Investor Relations -
Daniel Nathan,
Chief Technology Officer -
David Linetsky,
Senior Vice President - Life Sciences -
Amy VanDuyn,
Senior Vice President - Human Resources -
Michael Davidoff,
Senior Vice President - Marketing and Business Development -
Randy Rasmussen,
Chief Accounting Officer -
Amy Beth VanDuyn,
Sr. VP of HR -
Michael J. Davidoff,
Sr. VP of Marketing & Bus. Devel. -
Maureen McKinney,
VP of Corp. Communications -
Daniel Nathan,
Chief Technology Officer -
Randy Rasmussen,
Chief Financial Officer -
Ramin Sayar,
Director -
Venture Partners Ii, L.P.Hl...,
-
Lisa Egbuonu Davis,
Director -
Venture Management Co. V, L...,
-
Scott Perricelli,
Director -
Capital Iv, Llcllr Equity P...,
-
Yvonne Hui,
Principal Accounting Officer -
Allison C Hoffman,
General Counsel & Secretary -
Janet Gunzburg,
Principal Accounting Officer